Suppr超能文献

长效甲状腺刺激素和长效甲状腺刺激素保护剂均可刺激人体甲状腺的证据。

Evidence that both long-acting thyroid stimulator and long-acting thyroid stimulator-protector stimulate the human thyroid gland.

作者信息

Holmes S D, Dirmikis S M, Martin T J, Munro D S

出版信息

J Endocrinol. 1979 Feb;80(2):215-21. doi: 10.1677/joe.0.0800215.

Abstract

Thyroid-stimulating immunoglobulins were prepared from two potent sera, one contained long-acting thyroid stimulator (LATS) and the other contained both LATS and LATS-protector (LATS-P). The potencies of the immunoglobulin G (IgG) preparations were estimated in the McKenzie assay. The accumulation of cyclic AMP in mouse thyroid lobes was stimulated only by LATS--IgG; LATS-P--IgG was inactive. In contrast, both LATS-IgG and LATS-P--IgG were equally effective in slices of human thyroid.

摘要

从两份高效血清中制备了促甲状腺免疫球蛋白,一份含有长效甲状腺刺激素(LATS),另一份同时含有LATS和LATS保护物(LATS-P)。采用麦肯齐试验评估了免疫球蛋白G(IgG)制剂的效价。仅LATS-IgG能刺激小鼠甲状腺叶中环状AMP的积累;LATS-P-IgG无活性。相比之下,LATS-IgG和LATS-P-IgG在人甲状腺切片中同样有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验